部分椎體替代系統(tǒng)(PVBRs)是由一組神經(jīng)病學(xué)和整形外科醫(yī)生研制開發(fā)的，用以解決當(dāng)前退行性脊椎疾病治療不盡如人意之處。

這套MC+和ROI系統(tǒng)設(shè)計獨特，為外科醫(yī)生提供了廣闊的移植區(qū)域，這十分重要，可以在椎骨終板最強大區(qū)域的承重面放置移植物。這兩種系統(tǒng)在設(shè)計、材料、安裝設(shè)備以及使用的方便程度上都具有許多不同之處。

這兩套系統(tǒng)都獲得了美國食品藥品管理局的許可。這些系統(tǒng)都是由法國的LDR醫(yī)療公司研制開發(fā)的，得到了外科醫(yī)生的強力支持。迄今為止，這些產(chǎn)品已經(jīng)在超過3000例的手術(shù)中獲得了成功應(yīng)用。在美國這兩套系統(tǒng)都是由LDR的美國銷售伙伴LDR脊柱公司進行銷售。

LDR脊柱公司總裁兼首席執(zhí)行官Steve Whitlock說：“這兩套系統(tǒng)得到了外科學(xué)界的廣泛認(rèn)可，因為其簡便易用。我們是唯一的脊柱產(chǎn)品公司，可以定制并消毒我們的產(chǎn)品。盡管整個關(guān)節(jié)市場長期以來就從事這項業(yè)務(wù)，但是我們是唯一的進行定制和銷售脊柱關(guān)節(jié)產(chǎn)品的公司。”
 
Unique Implants for Spinal Fusion
 
Partial vertebral body replacement systems (PVBRs) were developed by a team of neurologic and orthopedic surgeons to address unmet or underserved needs in the treatment of degenerative spine disease.

The MC+ and ROI systems feature a unique design that provides surgeons with a large grafting area--an important feature that enables placement of the implants--and weight-bearing surfaces on the strongest areas of the vertebral endplate. The two systems offer many areas of differentiation in their design, material, instrumentation, and ease of use.

Both systems have been cleared by the U.S. Food and Drug Administration (FDA). The systems were developed in France by LDR Medical (Troyes, France) with strong surgeon involvement. To date, they have been successfully used in more than 3,000 procedures. Both systems will be distributed in the United States by LDR’s U.S. distribution partner, LDR Spine (Austin, TX, USA).

“Both systems have been well received by the surgeon community because of their simplified instrumentation,” said Steve Whitlock, president and CEO of LDR Spine. “We are the only spine company to individually package and sterilize our products. While the total joint market has long employed this approach, it is only a matter of time before all spine companies’ products are also packaged and delivered this way.”